Announced positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003 in patients with relapsed/refractory multiple myeloma ...
DT Midstream, Inc. (NYSE: DTM) today announced first quarter 2026 reported net income of $130 million, or $1.27 per diluted share. For the first quarter of 2026, Operating Earnings were $130 million, ...
Unity Software Inc. ( U) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT Ladies and gentlemen, thank you for joining us, and welcome to the Unity Technologies Q1 Earnings Call. [Operator Instructions] ...
Nexus has two core components: a context compiler and a composable retriever. The context compiler builds and organises knowledge around how your company operates. The composable retriever formats and ...
DT Midstream, Inc. (NYSE: DTM) today announced first quarter 2026 reported net income of $130 million, or $1.27 per diluted share. For the first quarter of ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes portfolio with the early access launch of Complex Genes.
USC researchers built a memristor that works at 700C, surviving conditions that killed every Venus probe. TetraMem is commercialising the technology for AI inference.
Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S.
Programmable optical particle transport based on structured light plays a crucial role in microscale manipulation. Scientists ...
Gas-powered counter-UAS platform completes airframe build and enters systems integration; initial flight testing planned for Q3 2026 ZenaTech, Inc. (NASDAQ:ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a ...
The goal of this article is to address the most common questions practitioners are asking today about gen AI in e-discovery.
We are reaffirming our full year 2026 guidance today, and Jade will walk through the financial details later in the call. I'll start with our digital asset strategy because I think there's more for ...